24/7 Patient Assistance: 760-405-8205

Joanne Weidhaas, MD

Radiation Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

specialties & services

  • Bio & Insurance Information

    Dr. Joanne Weidhass is a board-certified radiation oncologist based in Los Angeles, California. She graduated from the Tufts University School of Medicine and then did her internship at the Caritas Carney Hospital. She pursued her Radiation Oncology residency at the Memorial Sloan-Kettering Cancer Center. Dr. Weidhaas has been practicing for about two decades and is currently affiliated with the Lawrence and Memorial Hospital, Yale-New Haven Hospital, UCLA Medical Center, and Bridgeport Hospital. She has also authored several research papers.

    Insurance Accepted


  • Education & Training


    Tufts University

    Medical School


    Caritas Carney Hospital



    Memorial Sloan-Kettering Cancer Center


  • Board Certifications

    American Board of Radiology - Radiation Oncology

  • Hospital & Practice

    Bridgeport Hospital

    Languages: English/Spanish

    (203) 384-3000

    267 Grant St

    Bridgeport, Connecticut 06610

    Read More

    Lawrence + Memorial Hospital

    Languages: English/Spanish

    (860) 442-0711

    365 Montauk Ave

    New London, Connecticut 06320

    Read More

    University of California - Los Angeles Medical Center

    Languages: English/Spanish

    (310) 794-7953

    10833 Le Conte Ave

    Los Angeles, California 90095

    Read More

    Yale-New Haven Hospital

    Languages: English/Spanish

    (203) 688-4242

    20 York St.

    New Haven, Connecticut 06510

    Read More
  • Publications & Memberships

    Dr. Joanne Weidhaas has contributed to 3 publications.

    cel-mir-237 and its homologue, hsa-miR-125b, modulate the cellular response to ionizing radiation.

    Metheetrairut, C.,Adams, B. D.,Nallur, S.,Weidhaas, J. B.,Slack, F. J.; Oncogene. 2016 Jun 21.

    See more >>

    A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.

    Chung, C. H.,Lee, J. W.,Slebos, R. J.,Howard, J. D.,Perez, J.,Kang, H.,Fertig, E. J.,Considine, M.,Gilbert, J.,Murphy, B. A.,Nallur, S.,Paranjape, T.,Jordan, R. C.,Gar...; Ann. Oncol.. 2014 Aug 02.

    See more >>

    Targeted resequencing of the microRNAome and 3'UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer.

    Chen, X.,Paranjape, T.,Stahlhut, C.,McVeigh, T.,Keane, F.,Nallur, S.,Miller, N.,Kerin, M.,Deng, Y.,Yao, X.,Zhao, H.,Weidhaas, J. B.,Slack, F. J.; Oncogene. 2014 Jun 10.

    See more >>